Detalhe da pesquisa
1.
An expert panel's review on patients with hereditary angioedema switching from attenuated androgens to oral prophylactic therapy.
Allergy Asthma Proc
; 45(1): 44-49, 2024 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38151740
2.
Prophylactic use of an anti-activated factor XII monoclonal antibody, garadacimab, for patients with C1-esterase inhibitor-deficient hereditary angioedema: a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 399(10328): 945-955, 2022 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35219377
3.
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor.
N Engl J Med
; 376(12): 1131-1140, 2017 03 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28328347
4.
Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study.
Lancet Haematol
; 11(6): e436-e447, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38710185
5.
Letting the patients speak: an in-depth, qualitative research-based investigation of factors relevant to health-related quality of life in real-world patients with hereditary angioedema using subcutaneous C1 inhibitor replacement therapy.
Allergy Asthma Clin Immunol
; 17(1): 60, 2021 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34176500
6.
Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
Orphanet J Rare Dis
; 16(1): 86, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33588897
7.
Long-term efficacy and safety of subcutaneous C1-inhibitor in women with hereditary angioedema: subgroup analysis from an open-label extension of a phase 3 trial.
Allergy Asthma Clin Immunol
; 16: 8, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32042283
8.
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.
J Allergy Clin Immunol Pract
; 6(5): 1733-1741.e3, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29391286
9.
Correction to: Long-term health-related quality of life in patients treated with subcutaneous C1-inhibitor replacement therapy for the prevention of hereditary angioedema attacks: findings from the COMPACT open-label extension study.
Orphanet J Rare Dis
; 16(1): 329, 2021 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34321052
10.
IOP variation.
Ophthalmology
; 113(7): 1253; author reply 1254, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16815423